HealthQuill UK
The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too often undiagnosed and untreated.
Drugs Health Pharma

US regulator clears Glaukos Corp.’s drug to treat rare eye condition

The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too.

Read More
University of Cambridge scientists have developed a first-time imaging technique that helps visualise and quantify the early triggers of Parkinson’s — the world’s fastest-growing neurological disease.
Health Medical Research

UCL scientists trace Parkinson’s trigger in human brain tissue for first time

University of Cambridge scientists have developed a first-time imaging technique that helps visualise and quantify the early triggers of Parkinson’s — the world’s.

Read More
Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the Chinese company’s 12 potential medicines.
Drugs Health Pharma

GSK inks $500m deal with Jiangsu Hengrui for 12 potential medicines

HQ Team July 28, 2025: Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the.

Read More
Vicebio will receive potential milestone payments of up to $450 million based on development and regulatory achievements.
Drugs Health Pharma

Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates

 HQ Team July 22, 2025: Sanofi SA will acquire UK-based Vicebio Ltd. for $1.6 billion to gain access to vaccine candidates for respiratory.

Read More
Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion to gain access to a respiratory drug approved by the US regulator, according to a statement from Merck.
Drugs Health Pharma

Merck to acquire Verona Pharma for $10 billion to net respiratory drug 

HQ Team July 9, 2025: Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion and gain access to a.

Read More
The UK and Wellcome Trust will invest £600 million to create a new health data research service to accelerate the discovery of life-saving drugs, improve patient care and make Britain “the best place in the world” for medical research.
Drugs Health Pharma

UK, Wellcome to build ÂŁ600m health data service, fast-pace clinical trials

HQ Team May 19, 2025: The UK and Wellcome Trust will invest ÂŁ600 million to create a new health data research service to.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer therapy, nivolumab (Opdivo), offering a quicker administration option for eligible patients than the currently available drip treatment. 
Drugs Medical Pharma

UK regulator clears subcutaneous injection of Bristol Myers for cancers

HQ Team May 1, 2025: Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new under-the-skin injection version of the cancer.

Read More
King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss, in epileptic child patients.
Health Medical Research

UK researchers develop AI tool to detect brain lesions in epileptic children

King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss,.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Read More